aluates Reports

$ 0.0

Automative

Alzheimer Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: June 2024

Report Code: QYRE-Auto-21F12788

Global Alzheimer Drug Market Size Status and Forecast 2022 2028

BUY CHAPTERS

Alzheimer Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21F12788

Report

June 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biogen

Eli Lilly

Alzheon

Alzheimer Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Alzheimer Drug - Market

The global market for Alzheimer Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alzheimer Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Alzheimer Drug by region & country, by Type, and by Application.

The Alzheimer Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Drug.

Market Segmentation

Scope of Alzheimer Drug - Market Report

Report Metric	Details
Report Name	Alzheimer Drug - Market
CAGR	5%
Segment by Type:	Aducanumab Donepezil Rivastigmine Memantine Others
Segment by Application	Mild Alzheimer Moderate Alzheimer Severe Alzheimer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Eli Lilly, Alzheon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alzheimer Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Alzheimer Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Alzheimer Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Alzheimer Drug - Market report?

Ans: The main players in the Alzheimer Drug - Market are Biogen, Eli Lilly, Alzheon

What are the Application segmentation covered in the Alzheimer Drug - Market report?

Ans: The Applications covered in the Alzheimer Drug - Market report are Mild Alzheimer, Moderate Alzheimer, Severe Alzheimer

What are the Type segmentation covered in the Alzheimer Drug - Market report?

Ans: The Types covered in the Alzheimer Drug - Market report are Aducanumab, Donepezil, Rivastigmine, Memantine, Others

1 Market Overview

1.1 Alzheimer Drug Product Introduction

1.2 Global Alzheimer Drug Market Size Forecast

1.3 Alzheimer Drug Market Trends & Drivers

1.3.1 Alzheimer Drug Industry Trends

1.3.2 Alzheimer Drug Market Drivers & Opportunity

1.3.3 Alzheimer Drug Market Challenges

1.3.4 Alzheimer Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Alzheimer Drug Players Revenue Ranking (2023)

2.2 Global Alzheimer Drug Revenue by Company (2019-2024)

2.3 Key Companies Alzheimer Drug Manufacturing Base Distribution and Headquarters

2.4 Key Companies Alzheimer Drug Product Offered

2.5 Key Companies Time to Begin Mass Production of Alzheimer Drug

2.6 Alzheimer Drug Market Competitive Analysis

2.6.1 Alzheimer Drug Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Alzheimer Drug Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Aducanumab

3.1.2 Donepezil

3.1.3 Rivastigmine

3.1.4 Memantine

3.1.5 Others

3.2 Global Alzheimer Drug Sales Value by Type

3.2.1 Global Alzheimer Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Alzheimer Drug Sales Value, by Type (2019-2030)

3.2.3 Global Alzheimer Drug Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Mild Alzheimer

4.1.2 Moderate Alzheimer

4.1.3 Severe Alzheimer

4.2 Global Alzheimer Drug Sales Value by Application

4.2.1 Global Alzheimer Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Alzheimer Drug Sales Value, by Application (2019-2030)

4.2.3 Global Alzheimer Drug Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Alzheimer Drug Sales Value by Region

5.1.1 Global Alzheimer Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Alzheimer Drug Sales Value by Region (2019-2024)

5.1.3 Global Alzheimer Drug Sales Value by Region (2025-2030)

5.1.4 Global Alzheimer Drug Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Alzheimer Drug Sales Value, 2019-2030

5.2.2 North America Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Alzheimer Drug Sales Value, 2019-2030

5.3.2 Europe Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Alzheimer Drug Sales Value, 2019-2030

5.4.2 Asia Pacific Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Alzheimer Drug Sales Value, 2019-2030

5.5.2 South America Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Alzheimer Drug Sales Value, 2019-2030

5.6.2 Middle East & Africa Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Alzheimer Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Alzheimer Drug Sales Value

6.3 United States

6.3.1 United States Alzheimer Drug Sales Value, 2019-2030

6.3.2 United States Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Alzheimer Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Alzheimer Drug Sales Value, 2019-2030

6.4.2 Europe Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Alzheimer Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Alzheimer Drug Sales Value, 2019-2030

6.5.2 China Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Alzheimer Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Alzheimer Drug Sales Value, 2019-2030

6.6.2 Japan Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Alzheimer Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Alzheimer Drug Sales Value, 2019-2030

6.7.2 South Korea Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Alzheimer Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Alzheimer Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Alzheimer Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Alzheimer Drug Sales Value, 2019-2030

6.9.2 India Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Alzheimer Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Biogen

7.1.1 Biogen Profile

7.1.2 Biogen Main Business

7.1.3 Biogen Alzheimer Drug Products, Services and Solutions

7.1.4 Biogen Alzheimer Drug Revenue (US$ Million) & (2019-2024)

7.1.5 Biogen Recent Developments

7.2 Eli Lilly

7.2.1 Eli Lilly Profile

7.2.2 Eli Lilly Main Business

7.2.3 Eli Lilly Alzheimer Drug Products, Services and Solutions

7.2.4 Eli Lilly Alzheimer Drug Revenue (US$ Million) & (2019-2024)

7.2.5 Eli Lilly Recent Developments

7.3 Alzheon

7.3.1 Alzheon Profile

7.3.2 Alzheon Main Business

7.3.3 Alzheon Alzheimer Drug Products, Services and Solutions

7.3.4 Alzheon Alzheimer Drug Revenue (US$ Million) & (2019-2024)

7.3.5 Recent Developments

8 Industry Chain Analysis

8.1 Alzheimer Drug Industrial Chain

8.2 Alzheimer Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Alzheimer Drug Sales Model

8.5.2 Sales Channel

8.5.3 Alzheimer Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Biogen

Eli Lilly

Alzheon

List of Tables

Table 1. Alzheimer Drug Market Trends

Table 2. Alzheimer Drug Market Drivers & Opportunity

Table 3. Alzheimer Drug Market Challenges

Table 4. Alzheimer Drug Market Restraints

Table 5. Global Alzheimer Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Alzheimer Drug Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Alzheimer Drug Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Alzheimer Drug Product Type

Table 9. Key Companies Time to Begin Mass Production of Alzheimer Drug

Table 10. Global Alzheimer Drug Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Alzheimer Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Alzheimer Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Alzheimer Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Alzheimer Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Alzheimer Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Alzheimer Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Alzheimer Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Alzheimer Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Alzheimer Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Alzheimer Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Alzheimer Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Alzheimer Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Alzheimer Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Alzheimer Drug Sales Value by Region (2019-2024) & (%)

Table 27. Global Alzheimer Drug Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Alzheimer Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Alzheimer Drug Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Alzheimer Drug Sales Value, (2025-2030) & (US$ Million)

Table 31. Biogen Basic Information List

Table 32. Biogen Description and Business Overview

Table 33. Biogen Alzheimer Drug Products, Services and Solutions

Table 34. Revenue (US$ Million) in Alzheimer Drug Business of Biogen (2019-2024)

Table 35. Biogen Recent Developments

Table 36. Eli Lilly Basic Information List

Table 37. Eli Lilly Description and Business Overview

Table 38. Eli Lilly Alzheimer Drug Products, Services and Solutions

Table 39. Revenue (US$ Million) in Alzheimer Drug Business of Eli Lilly (2019-2024)

Table 40. Eli Lilly Recent Developments

Table 41. Alzheon Basic Information List

Table 42. Alzheon Description and Business Overview

Table 43. Alzheon Alzheimer Drug Products, Services and Solutions

Table 44. Revenue (US$ Million) in Alzheimer Drug Business of Alzheon (2019-2024)

Table 45. Alzheon Recent Developments

Table 46. Key Raw Materials Lists

Table 47. Raw Materials Key Suppliers Lists

Table 48. Alzheimer Drug Downstream Customers

Table 49. Alzheimer Drug Distributors List

Table 50. Research Programs/Design for This Report

Table 51. Key Data Information from Secondary Sources

Table 52. Key Data Information from Primary Sources

Table 53. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Alzheimer Drug Product Picture

Figure 2. Global Alzheimer Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Alzheimer Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Alzheimer Drug Report Years Considered

Figure 5. Global Alzheimer Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Alzheimer Drug Revenue in 2023

Figure 7. Alzheimer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Aducanumab Picture

Figure 9. Donepezil Picture

Figure 10. Rivastigmine Picture

Figure 11. Memantine Picture

Figure 12. Others Picture

Figure 13. Global Alzheimer Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Alzheimer Drug Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Mild Alzheimer

Figure 16. Product Picture of Moderate Alzheimer

Figure 17. Product Picture of Severe Alzheimer

Figure 18. Global Alzheimer Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Alzheimer Drug Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Alzheimer Drug Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Alzheimer Drug Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Alzheimer Drug Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Alzheimer Drug Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Alzheimer Drug Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Alzheimer Drug Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Alzheimer Drug Sales Value (%), (2019-2030)

Figure 31. United States Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 37. China Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 39. China Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 49. India Alzheimer Drug Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Alzheimer Drug Sales Value by Type (%), 2023 VS 2030

Figure 51. India Alzheimer Drug Sales Value by Application (%), 2023 VS 2030

Figure 52. Alzheimer Drug Industrial Chain

Figure 53. Alzheimer Drug Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions